LANTERN PHARMA INC
NASDAQ: LTRN (Lantern Pharma Inc.)
Kemas kini terakhir: 56 minit lalu1.93
-0.09 (-4.46%)
| Penutupan Terdahulu | 2.02 |
| Jumlah Dagangan | 162,607 |
| Harga / Buku (P/B) | 9.74 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.84 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.16% |
| Nisbah Semasa (MRQ) | 4.86 |
| Aliran Tunai Operasi (OCF TTM) | -19.12 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.95 M |
| Pulangan Atas Aset (ROA TTM) | -43.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -75.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Lantern Pharma Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -1.50 |
|
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.10% |
| % Dimiliki oleh Institusi | 21.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Empery Asset Management, Lp | 30 Jun 2026 | 842,669 |
| Cm Management, Llc | 30 Jun 2026 | 500,000 |
| Bios Capital Management, Lp | 30 Jun 2026 | 249,397 |
| Westside Investment Management, Inc. | 30 Jun 2026 | 47,850 |
| Quadrature Capital Ltd | 30 Jun 2026 | 39,593 |
| Newedge Advisors, Llc | 30 Jun 2026 | 27,049 |
| Horizon Kinetics Asset Management Llc | 30 Jun 2026 | 25,164 |
| Davenport & Co Llc | 30 Jun 2026 | 23,814 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |